Sort
17,828 grants matching “crispr”
Pathomechanisms of SCN3A-related neurodevelopmental disorder
$528,326Ethan M Goldberg · Children'S Hosp Of Philadelphia · R01 · FY2023 · NS
Critical Lipid Species in the Hepatovirus Lifecycle
$528,265Stanley M Lemon · Univ Of North Carolina Chapel Hill · R01 · FY2020 · AI
Epstein-Barr Virus Driven Tonsillar Versus Peripheral B-cell One-Carbon Metabolic Network Remodeling
$528,226Benjamin Elison Gewurz · Brigham And Women'S Hospital · R01 · FY2024 · DE
Activation of Proto-Oncogenes by Chromosomal Translocation
$528,207Peter Aplan · Division Of Clinical Sciences - Nci · ZIA · FY2018 · CA
Computational analysis of complex genetic interactions
$528,000David Martin McCandlish · Cold Spring Harbor Laboratory · R35 · FY2025 · GM
Novel Genome Editing for the Treatment of Glaucoma
$527,925Val C Sheffield · University Of Iowa · R01 · FY2021 · EY
Mechanistic analysis and allellic genome editing of iPSC-derived dominant LCA model
$527,898Deepak Ashok Lamba · University Of California, San Francisco · R01 · FY2023 · EY
Androgen Activation of Innate Immune Signaling to Enhance Prostate Cancer Immune Response
$527,817Sushant Krishna Kachhap · Johns Hopkins University · R01 · FY2022 · CA
Credentialing Models of Invasive Lobular Breast Cancer for Translational Research
$527,799Steffi Oesterreich · University Of Pittsburgh At Pittsburgh · R01 · FY2025 · CA
Role of BAZ2A in MLL-r leukemia and therapeutic response
$527,738Chun-Wei David Chen · Beckman Research Institute/City Of Hope · R01 · FY2021 · CA
Mechanisms of mechanotransduction during neural tube morphogenesis
$527,608Xiaowei Lu · University Of Virginia · R01 · FY2025 · HD
Mechanisms of mechanotransduction during neural tube morphogenesis
$527,608Xiaowei Lu · University Of Virginia · R01 · FY2023 · HD
Composing CODAs to cervical cancer screening through an integrated CRISPR and fluorescent nucleic acid approach
$527,535Cesar M Castro · Massachusetts General Hospital · U01 · FY2024 · CA
MODULATION OF CD5 SIGNALING TO ENHANCE ADOPTIVE T-CELL THERAPIES FOR CANCER
$527,525Marco Ruella · University Of Pennsylvania · R37 · FY2022 · CA
MODULATION OF CD5 SIGNALING TO ENHANCE ADOPTIVE T-CELL THERAPIES FOR CANCER
$527,525Marco Ruella · University Of Pennsylvania · R37 · FY2025 · CA
Investigating Max as a tumor suppressor gene in small cell lung cancer and other neuroendocrine tumors
$527,348Robert Neil Eisenman · Fred Hutchinson Cancer Center · R01 · FY2024 · CA
Mechanisms by which the ketone body β-hydroxybutyrate counteracts tau pathogenesis
$527,335Xu Chen · University Of California, San Diego · R01 · FY2024 · AG
Neuropeptide S and arousal
$526,895Luis De Lecea · Stanford University · R01 · FY2023 · MH
Targeting SMARCA2 as a therapeutic strategy in SMARCA4 mutant lung cancer
$526,882Yonathan Lissanu · University Of Tx Md Anderson Can Ctr · R01 · FY2023 · CA
DNA repair alterations in metastatic prostate cancer: functional and therapeutic implications
$526,795Alan Ashworth · University Of California, San Francisco · R01 · FY2019 · CA
Framework for Advances in Reprogenomics Ethics & Regulation (FAIRER)
$526,648Marsha Mabry Michie · Case Western Reserve University · R01 · FY2021 · HG
Targeting ATM to boost systemic effects of radiotherapy and immunotherapy
$526,563Chuan-Yuan Li · Duke University · R01 · FY2021 · CA
Targeting ATM to boost systemic effects of radiotherapy and immunotherapy
$526,563Yunyan Jennifer Jennifer Zhang · Duke University · R01 · FY2025 · CA
Understanding intrinsic resistance to direct KRAS inhibition in colorectal cancers
$526,540John D Gordan · University Of California, San Francisco · R37 · FY2025 · CA
Enhancing endoplasmic reticulum stress in ovarian cancer
$526,459Ratna K Vadlamudi · University Of Texas Hlth Science Center · R01 · FY2025 · CA